Ajay Bansal - Net Worth and Insider Trading

Ajay Bansal Net Worth

The estimated net worth of Ajay Bansal is at least $6,829 dollars as of 2024-04-25. Ajay Bansal is the Former CFO of Nektar Therapeutics and owns about 5,166 shares of Nektar Therapeutics (NKTR) stock worth over $6,819. Ajay Bansal is also the CFO of ViewRay Inc and owns about 70,104 shares of ViewRay Inc (VRAYQ) stock worth over $10. Details can be seen in Ajay Bansal's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Ajay Bansal has not made any transactions after 2017-01-18 and currently still holds the listed stock(s).

Transaction Summary of Ajay Bansal

To

Ajay Bansal Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Ajay Bansal owns 5 companies in total, including Urovant Sciences Ltd (UROV) , ViewRay Inc (VRAYQ) , and Traws Pharma Inc (TRAW) among others .

Click here to see the complete history of Ajay Bansal’s form 4 insider trades.

Insider Ownership Summary of Ajay Bansal

Ticker Comapny Transaction Date Type of Owner
UROV Urovant Sciences Ltd 2020-05-01 PFO;CFO/Urovant Sciences & Inc.
VRAYQ ViewRay Inc 2018-04-16 Chief Financial Officer
TRAW Traws Pharma Inc 2013-07-24 Chief Financial Officer
LXRX Lexicon Pharmaceuticals Inc 2009-06-02 EVP Corp Dev and CFO
NKTR Nektar Therapeutics 2006-03-10 CFO & VP Finance & Admin

Ajay Bansal Latest Holdings Summary

Ajay Bansal currently owns a total of 2 stocks. Among these stocks, Ajay Bansal owns 5,166 shares of Nektar Therapeutics (NKTR) as of March 10, 2006, with a value of $6,819 and a weighting of 99.86%. Ajay Bansal also owns 70,104 shares of ViewRay Inc (VRAYQ) as of January 18, 2017, with a value of $10 and a weighting of 0.14%.

Latest Holdings of Ajay Bansal

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
NKTR Nektar Therapeutics 2006-03-10 5,166 1.32 6,819
VRAYQ ViewRay Inc 2017-01-18 70,104 0.00 10

Holding Weightings of Ajay Bansal


Ajay Bansal Form 4 Trading Tracker

According to the SEC Form 4 filings, Ajay Bansal has made a total of 0 transactions in Nektar Therapeutics (NKTR) over the past 5 years. The most-recent trade in Nektar Therapeutics is the sale of 5,167 shares on March 10, 2006, which brought Ajay Bansal around $102,927.

According to the SEC Form 4 filings, Ajay Bansal has made a total of 0 transactions in ViewRay Inc (VRAYQ) over the past 5 years. The most-recent trade in ViewRay Inc is the acquisition of 62,597 shares on January 18, 2017, which cost Ajay Bansal around $198,432.

Insider Trading History of Ajay Bansal

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Ajay Bansal Trading Performance

GuruFocus tracks the stock performance after each of Ajay Bansal's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Ajay Bansal is 122.93%. GuruFocus also compares Ajay Bansal's trading performance to market benchmark return within the same time period. The performance of stocks bought by Ajay Bansal within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Ajay Bansal's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Ajay Bansal

Average Return

174.52%

Average return per transaction

Outperforming Transactions

100%

1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 60.83 122.93 97.45 174.52 57.61 -0.21
Relative Return to S&P 500(%) 57.34 119.84 89.14 151.36 49.19 -13.81

Ajay Bansal Ownership Network

Ownership Network List of Ajay Bansal

No Data

Ownership Network Relation of Ajay Bansal


Ajay Bansal Owned Company Details

What does Urovant Sciences Ltd do?

Who are the key executives at Urovant Sciences Ltd?

Ajay Bansal is the PFO;CFO/Urovant Sciences & Inc. of Urovant Sciences Ltd. Other key executives at Urovant Sciences Ltd include SVP & Commercial & USI Walt Johnston , CMO/Urovant Sciences & Inc. Haag-molkenteller Cornelia , and GC/Urovant Sciences & Inc. Bryan E. Smith .

Urovant Sciences Ltd (UROV) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Urovant Sciences Ltd (UROV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Urovant Sciences Ltd (UROV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Urovant Sciences Ltd (UROV)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Urovant Sciences Ltd Insider Transactions

No Available Data

Ajay Bansal Mailing Address

Above is the net worth, insider trading, and ownership report for Ajay Bansal. You might contact Ajay Bansal via mailing address: C/o Urovant Sciences, Inc., 5281 California Avenue, Suite 100, Irvine Ca 92617.

Discussions on Ajay Bansal

No discussions yet.